Grants and Contributions:
Title:
Magnetic-Based Reagents for Viral RNA Extraction in Clinical and Point-of-Care Applications
Agreement Number:
955723
Agreement Value:
$266,500.00
Agreement Date:
Aug 24, 2020 - Nov 23, 2020
Description:
COVID-19 Challenge: To develop a proof of concept for The National Research Council Canada (NRC) is seeking a solution for reagents required for nucleic acid sample preparation and rapid and efficient SARS-CoV-2 Ribonucleic Acid (RNA) extraction in order to perform downstream molecular diagnostics of COVID-19 with capability to integrate within existing and/or potential microfluidic platforms for sample-to-answer solutions that can be deployed on the frontline for rapid testing.
Organization:
National Research Council Canada
Expected Results:
Grow Canadian companies through direct funding to support early stage, pre-commercial research and development, late stage prototypes, and to accelerate commercialization.
Location:
Montreal, Quebec, CA H3N 1Y4
Reference Number:
172-2020-2021-Q2-955723
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
742964521
Recipient Type:
For-profit organization
Recipient's Operating Name:
Galenvs Sciences Inc.
Recipient's Legal Name:
Galenvs Sciences Inc.
Research Organization:
National Research Council Canada/Conseil national de recherches Canada
Federal Riding Name:
Papineau
Federal Riding Number:
24055
Program:
Innovative Solutions Canada
Program Purpose:
Fuel the development and adoption of technological innovation in Canada
Coverage:
• Support the scale up and growth of Canada's innovators and entrepreneurs by having the federal government act as a first customer. • Stimuler l'expansion et la croissance des innovateurs et entrepreneurs canadiens en faisant du gouvernement fédéral le premier client des innovations canadiennes.
NAICS Code:
621510